
In a target trial emulation using N3C data, adults prescribed metformin within six days of SARS-CoV-2 infection had about half the risk of long COVID or death within six months.
A modeling study from Imperial College shows the COVID-19 pandemic may have significant effect on mortality among other infectious disease patients.
Segment Description: A modeling study from Imperial College shows the COVID-19 pandemic may have significant effect on mortality among other infectious disease patients.
More information






